Recurrent Respiratory Infections a product for special medical purposes capable of helping to limit the number of respiratory infections is commercially available. This product, which has been developed and patented by Italian researchers, as well as tested in several clinical studies of national and international significance, is marketed under the brand name PRO-TH1.